WVP
DERM

Worth Venture Partners’s Dermira, Inc. DERM Stock Holding History

Worth Venture Partners’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,400
Closed -$7K – 127
2018
Q1 		$7K Buy
+11,400
New +$248K 0.01% 98

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Worth Venture Partners's DERM Position: Q3 2019 in Review

Worth Venture Partners sold out of Dermira, Inc. (DERM) in Q3 2019, closing a stake of 71,372 shares — an estimated $683K sold.

Worth Venture Partners first reported a position in DERM in Q1 2019 and held it in 2 quarters. The position peaked at $683K in Q2 2019. 131 funds tracked by Wall St. Rank hold DERM as of Q3 2019.

  • Worth Venture Partners reported no remaining Dermira, Inc. position as of Q3 2019 after selling out during the quarter.
  • Worth Venture Partners sold 71,372 Dermira, Inc. shares in Q3 2019, an estimated $683K.
  • Worth Venture Partners first reported a position in Dermira, Inc. in Q1 2019 and held it in 2 quarters.
  • Worth Venture Partners's Dermira, Inc. position peaked at $683K in Q2 2019.
  • 131 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2019.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.